Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Ex-NHL stars’ Seven7 joins Altor in strategic play for CCM Hockey
Ex-NHL stars’ Seven7 joins Altor in strategic play for CCM Hockey Seven7, the private equity firm founded by former NHL stars Martin St. Louis and Jeff Hamilton, has taken a minority stake in leading hockey brand CCM, joining forces with existing backer Altor Equity...
LDC takes 45% stake in virtual law firm Harper James amid tech-driven expansion push
LDC takes 45% stake in virtual law firm Harper James amid tech-driven expansion push LDC has acquired a 45% stake in Harper James, a fully remote UK-based law firm, as part of a strategic move to accelerate digital transformation and fuel expansion. The private equity...
Accounting firms turn to IPOs as private equity reshapes sector dynamics
Accounting firms turn to IPOs as private equity reshapes sector dynamics Private equity’s deepening influence on accounting firms is prompting a new wave of IPO discussions, as more players seek alternative funding paths and long-term strategic flexibility. The shift...